Real-time enrollment status for this recurrent platinum-sensitive fallopian tube endometrioid adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 29, 2026 at 8:06 PM UTC
| NCT Number | NCT07504588 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 87 participants |
| Active Locations | 7 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 29, 2026 (20 hours ago) |
As of September 29, 2026: Clinical trial NCT07504588 is currently recruiting participants. This phase2 study for recurrent platinum-sensitive fallopian tube endometrioid adenocarcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07504588 is actively recruiting participants as of September 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07504588 was last updated 20 hours ago (September 29, 2026). HelloStudys verifies this status automatically.